Switching from name-brand drugs could save €125m in budget, pharmacists say

The Irish Pharmacy Union says a policy on "biosimilar" drugs has been promised for years, but never delivered.

Pharmacists say €125 million a year could be freed up in the health budget by switching from name-brand drugs to similar ones made in Ireland.

The Irish Pharmacy Union says a policy on these "biosimilar" drugs has been promised for years, but never delivered.